TY - JOUR
T1 - Geometric Microstructural Characteristics of White Matter Differentiate Patients With Facial Dyskinesias and Palsy
AU - Zhu, Hua
AU - Yang, Aocai
AU - Luan, Jixin
AU - Xu, Manxi
AU - Liu, Bing
AU - Lv, Kuan
AU - Hu, Pianpian
AU - Shmuel, Amir
AU - Zhu, Haogang
AU - Yuan, Zhen
AU - Shu, Ni
AU - Cheng, Jian
AU - Ma, Guolin
N1 - Publisher Copyright:
© 2026 The Author(s). CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
PY - 2026/2
Y1 - 2026/2
N2 - Purpose: The heterogeneous and homogeneous clinical manifestations of peripheral facial palsy (FP), hemifacial spasm (HFS), and Meige's syndrome (MS) complicate the differentiation of diagnoses for these facial motor diseases. To comprehensively investigate the white matter microstructural characteristics in patients with facial dyskinesias and palsy using geometric and integrity metrics in DTI. Material and Methods: In this prospective study conducted from September 2020 to January 2022, patients with FP, HFS, and MS, as well as sex-matched healthy control subjects, underwent 3.0 T MRI. Geometric metrics (i.e., splay, bend, twist, and total distortion) based on “Director Field Analysis” and fractional anisotropy (FA) and mean diffusivity (MD) were calculated from DTI data. Cross-sectional tract-based spatial statistics were performed among FP, HFS, MS patients, and healthy controls. The correlation between disease severity and DTI metrics was evaluated. Additionally, the geometric microstructural properties combining FA and MD were used to classify FP, HFS, and MS patients using machine learning methods. Results: Geometric metrics and FA/MD were widely altered across white matter in FP and HFS patients compared with healthy controls. However, in MS patients only DFA metrics were significantly altered. FA and DFA values strongly correlated with the severity of facial movement disorder in FP patients. Combing conventional FA/MD value with DFA metrics enabled the diagnostic differentiation of FP and HFS from MS. Conclusion: Our findings demonstrated that the geometric microstructural information of white matter fibers could provide novel insight into the underlying pathological changes in facial dyskinesias and palsy.
AB - Purpose: The heterogeneous and homogeneous clinical manifestations of peripheral facial palsy (FP), hemifacial spasm (HFS), and Meige's syndrome (MS) complicate the differentiation of diagnoses for these facial motor diseases. To comprehensively investigate the white matter microstructural characteristics in patients with facial dyskinesias and palsy using geometric and integrity metrics in DTI. Material and Methods: In this prospective study conducted from September 2020 to January 2022, patients with FP, HFS, and MS, as well as sex-matched healthy control subjects, underwent 3.0 T MRI. Geometric metrics (i.e., splay, bend, twist, and total distortion) based on “Director Field Analysis” and fractional anisotropy (FA) and mean diffusivity (MD) were calculated from DTI data. Cross-sectional tract-based spatial statistics were performed among FP, HFS, MS patients, and healthy controls. The correlation between disease severity and DTI metrics was evaluated. Additionally, the geometric microstructural properties combining FA and MD were used to classify FP, HFS, and MS patients using machine learning methods. Results: Geometric metrics and FA/MD were widely altered across white matter in FP and HFS patients compared with healthy controls. However, in MS patients only DFA metrics were significantly altered. FA and DFA values strongly correlated with the severity of facial movement disorder in FP patients. Combing conventional FA/MD value with DFA metrics enabled the diagnostic differentiation of FP and HFS from MS. Conclusion: Our findings demonstrated that the geometric microstructural information of white matter fibers could provide novel insight into the underlying pathological changes in facial dyskinesias and palsy.
KW - Meige's syndrome
KW - diffusion tensor imaging
KW - facial palsy
KW - facial paralysis
UR - https://www.scopus.com/pages/publications/105028834871
U2 - 10.1002/cns.70733
DO - 10.1002/cns.70733
M3 - 文章
C2 - 41603069
AN - SCOPUS:105028834871
SN - 1755-5930
VL - 32
JO - CNS Neuroscience and Therapeutics
JF - CNS Neuroscience and Therapeutics
IS - 2
M1 - e70733
ER -